Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1561 - 1568 of 12016 results
Proposed Overhaul of HSR Premerger Notification Process
June 28, 2023| Blog| Viewpoint
EXCLUSIVE RIGHTS: Intellectual Property — Bad Dog? “Bad Spaniels” at SCOTUS
June 27, 2023| Podcast| Viewpoint
Cross-border Considerations for the Life Sciences Industry
June 27, 2023| Blog| Viewpoint
Recent Developments Signal Headwinds for Homeopathic Drug Products
June 26, 2023| Blog| Viewpoint
PE Exits A Growing Segment Of Deals With Earnout Provisions
June 26, 2023| News
SEC Approves NYSE and Nasdaq Compensation “Clawback” Listing Standards; Compliance Required by December 1, 2023
June 23, 2023| Alert| Viewpoint
Advancing the SAFE Innovation in the AI Age Framework — AI: The Washington Report
June 23, 2023| Article| Viewpoint
A Closer Look at New York State’s Proposed Ban of Non-Compete Agreements
June 23, 2023| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|